CARLSMED, INC. CARL · Stock Open CARLSMED, INC. in new tab
Analyst price targets
Recent rating changes, newest first
CARLSMED, INC. Analysis (CARL)
Is CARLSMED, INC. a good investment? CARLSMED, INC. (CARL) is currently trading at 14.61 USD. Market analysts have a consensus price target of 19.40 USD. This suggests a potential upside from current levels.
Earnings Schedule: CARLSMED, INC. is expected to release its next earnings report on Nov. 5, 2026. The market consensus estimate for Forward EPS is -1.38.
Investor FAQ
Does CARLSMED, INC. pay a dividend?
No, it does not currently pay a dividend.
What asset class is CARLSMED, INC.?
CARLSMED, INC. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 5, 2026. The company currently has a trailing EPS of -1.08.
Company Profile
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
Community Discussion